Levonorgestrel linked to Deep Vein Thrombosis, reveals IPC Drug safety alert - Video
|
Overview
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of August, has revealed that Levonorgestrel, a synthetic progestogen popularly used in contraception and hormone therapy is linked with Adverse Drug Reactions (ADRs) named Deep Vein Thrombosis.
This came after a preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.
For more details, check out the link given below:
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
